A Cambridge biotech has taken over development of a Roche rare disease drug, Cue Biopharma signed a deal with Boehringer ...

The finding means that building larger AI models for protein design, and feeding them more data, will produce predictably ...

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

The U.S. biotech sector had already been through a brutal few years before the latest market crash. Robert F. Kennedy Jr.’s ...

Elevation Oncology has become the second biotech this week to face calls from an activist investor to wind down the company.

With tariffs pushing manufacturing home to the U.S., Pitchbook warns of reduced M&A activity and venture capital funding.

“We were given the opportunity to engage with Genentech in 1977, two years before its IPO [initial public offering], and we ...

While we drown breakthrough-science in red tape, China has a laser-like focus on speeding up scientific progress and adopting ...

Find out why Europe has fallen behind the U.S. and China in the AI race in biotech and what it needs to do to catch up.

A 1975 meeting at the Asilomar Conference Center in Pacific Grove, California, shaped a new safety regime for recombinant DNA ...